Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.
about
Glucocorticosteroids for viral hepatitis CInterferon therapy in hepatitis C leading to chronic type 1 diabetesImmunogenicity and other problems associated with the use of biopharmaceuticals.Type B insulin resistance developing during interferon-alpha therapy.Safety, Tolerability, and Immunogenicity of InterferonsRelationship of hepatitis C virus infection with diabetes in the U.S. population.Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.Clinical and genetic characteristics of patients with type 1 diabetes associated with interferon therapy.Type 1 diabetes and interferon therapy: a nationwide survey in Japan.Diabetes and Hepatitis C: A Two-Way Association.Interferons as pathogenic effectors in autoimmunity.Type I interferons mediate pancreatic toxicities of PERK inhibition.Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice.Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B.Type I IFNs and their role in the development of autoimmune diseases.Type I interferon therapy and its role in autoimmunity.Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review.The potential role of dendritic cells in the therapy of Type 1 diabetes.Drug-Induced Hyperglycaemia and Diabetes.Extrahepatic manifestations of HCV: the role of direct acting antivirals.Type I Interferon Is a Catastrophic Feature of the Diabetic Islet MicroenvironmentProgression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signalingClassification and characteristics of interferon-related diabetes mellitus in Japan.Potential role of type I interferon in the pathogenic process leading to type 1 diabetes.Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma.
P2860
Q24247204-3D368AF4-8586-455E-A0ED-75316FA5ABF2Q28080876-348AFFF5-6C1B-4C6A-B0C8-134AEAEC9356Q33416851-DF41BE10-0C99-4438-A499-6BDA1FD8548CQ33418525-BAF8BB79-AD3A-479C-8F78-DB837F3565A3Q33435810-A9D58171-D7D8-410A-AEA4-4F207DBBE07FQ34005936-8937AD00-30BE-43F6-B8C2-3C66D39A6144Q34099620-15FEF065-46D9-4716-A676-E9353A05C54CQ34507292-A00355C9-ACDE-4FEF-8ECE-34A65FBBB5EFQ35179925-00E4865F-B378-490D-8AB8-6C0FFFA2A082Q36056076-2FDF7B3F-5DFD-41CF-8DAA-0A99EE368B87Q36079852-D199528A-01F5-49ED-9BCF-059CCC9A8CBEQ36394344-90873809-9BF0-44AD-983D-C2F7DB4F9C19Q36711831-DF23A2E0-8C15-45CF-9D1C-4802906543AFQ36858608-2EA91023-7C9A-417E-878D-381EAA4FC5C1Q37023012-B62BB09B-4A09-460D-88E5-C9CFB9BC153CQ37335135-DD5F0858-60AF-4AB2-AC85-FE25C0772AD4Q37528458-17683B47-FD5F-445C-B4A8-B59D78ECC1F9Q37713730-52EA0A80-E9F8-4784-810F-34DD19785E9FQ37851006-6A29C0AF-BE15-42E9-9D09-2F73FC511B87Q38033554-6FF00AC4-40CE-4963-845A-758BBF3BEB4CQ38110933-E339CDCD-BB1F-4977-8054-BAB267D00E8DQ38586781-179EA5F2-D118-458C-9714-18F7651E3E7BQ38684508-53AEE201-E6D6-4D6F-8A92-AD08A4236FC5Q41672962-74800392-AD4F-4DCD-8280-432BAB01F2D4Q42291845-21128ACC-6985-4E72-9927-86DBD3158D29Q43471869-57B956E7-D8A1-4DF6-9AE6-4541295A75BAQ47548945-2A4215BF-A803-4125-B9EF-773A2AF320ADQ53428967-81F41CF6-545C-48A0-999D-58D8F3C4B27A
P2860
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@ast
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@en
type
label
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@ast
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@en
prefLabel
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@ast
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@en
P2093
P2860
P1476
Type 1 diabetes mellitus in pa ...... and after interferon therapy.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2003.01681.X
P407
P577
2003-09-01T00:00:00Z